Competition delays multi-drug resistance evolution during combination therapy

DOI10.1016/J.JTBI.2020.110524MaRDI QIDQ2225995zbMATH OpenOpenAlexWikidataFDO

Authors Ernesto Berríos-Caro, Danna R. Gifford, Tobias Galla

Publication date 11 February 2021

Published in Journal of Theoretical Biology (Search for Journal in Brave)

Copyright license Creative Commons Attribution 4.0 International

Full work available at URL https://doi.org/10.1016/j.jtbi.2020.110524

zbMATH Keywords

combination therapyprobability of drug resistancesimulation of individual-based modelsstochastic processes

Mathematics Subject Classification ID

Medical applications (general) (92C50)

Recommendations

• Combination therapies and intra-tumoral competition: insights from mathematical modeling
• The impact of competition between cancer cells and healthy cells on optimal drug delivery
• Evolution of resistance to anti-cancer therapy during general dosing schedules
• Dynamics of an HIV infection model with two infection routes and evolutionary competition between two viral strains
• Stochastic modeling of drug resistance in cancer

Cites work

• A competition model of HIV with recombination effect
• Alternatives to Lotka-Volterra competition: Models of intermediate complexity
• Analysis of tracer particle migration in inhomogeneous turbulence
• Evolution of resistance to anti-cancer therapy during general dosing schedules
• Evolutionary dynamics of invasion and escape
• Global Models of Growth and Competition
• scientific article; zbMATH DE number 3174818 (Why is no real title available?)
• scientific article; zbMATH DE number 46731 (Why is no real title available?)
• On Approximating the Moments of the Equilibrium Distribution of a Stochastic Logistic Model
• On the cumulants of population size for the stochastic power law logistic model
• Simulation of nonhomogeneous poisson processes by thinning

Cited in

(3)

• Drug concentration heterogeneity facilitates the evolution of drug resistance
• A birth-death model to understand bacterial antimicrobial heteroresistance from time-kill curves
• Probability of antibiotic resistance during treatment in stochastic PK/PD-based bacterial model with distinct drug and mutation modes

This page was built for publication: Competition delays multi-drug resistance evolution during combination therapy

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2225995)